{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:10:34Z","timestamp":1762492234041,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijcha.2020.100660","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T14:28:35Z","timestamp":1602772115000},"page":"100660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2936-8805","authenticated-orcid":false,"given":"Philip","family":"Braude","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0318-8865","authenticated-orcid":false,"given":"Ben","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-637X","authenticated-orcid":false,"given":"Roxanna","family":"Short","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Vilches-Moraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Verduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndsay","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeline","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence J.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Stechman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemima","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5126-0943","authenticated-orcid":false,"given":"Eilidh","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Einarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Rickard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-6569","authenticated-orcid":false,"given":"Mark","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hesford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4312-1905","authenticated-orcid":false,"given":"Fenella","family":"Barlow-Pay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1515-5094","authenticated-orcid":false,"given":"Enrico","family":"Clini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyo Kyaw","family":"Myint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9969-9760","authenticated-orcid":false,"given":"Susan","family":"Moug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Drugs and the Renin-Angiotensin System in Covid-19","author":"Aronson","key":"10.1016\/j.ijcha.2020.100660_b0005"},{"key":"10.1016\/j.ijcha.2020.100660_b0010","doi-asserted-by":"crossref","unstructured":"L. Fang, G. Karakiulakis, M. Roth, Antihypertensive drugs and risk of COVID-19? \u2013 Authors\u2019 reply, vol. 8. The Lancet. Respiratory Medicine. NLM (Medline), 2020, p. e32\u20133.","DOI":"10.1016\/S2213-2600(20)30159-4"},{"key":"10.1016\/j.ijcha.2020.100660_b0015","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"28","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"issue":"10223","key":"10.1016\/j.ijcha.2020.100660_b0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10229","key":"10.1016\/j.ijcha.2020.100660_b0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2020.100660_b0030","first-page":"368","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study","volume":"26","author":"Chen","year":"2020","journal-title":"BMJ"},{"issue":"9200","key":"10.1016\/j.ijcha.2020.100660_b0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Gerstein","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2020.100660_b0040","doi-asserted-by":"crossref","unstructured":"S. Yusuf, Effects of an angiotensin-converting\u2013enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, N Engl. J. Med. [Internet] 342(3) (2000 Jan 20) 145\u2013153. Available from: http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJM200001203420301 (cited 2020 May 9).","DOI":"10.1056\/NEJM200001203420301"},{"key":"10.1016\/j.ijcha.2020.100660_b0045","unstructured":"Prescriptions Dispensed in the Community - Statistics for England, 2007-2017 - NHS Digital [Internet] (cited 2020 May 9). Available from: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/prescriptions-dispensed-in-the-community\/prescriptions-dispensed-in-the-community-england---2007---2017."},{"key":"10.1016\/j.ijcha.2020.100660_b0050","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of covid-19","author":"Reynolds","year":"2020","journal-title":"N Engl. J. Med. [Internet]"},{"key":"10.1016\/j.ijcha.2020.100660_b0055","doi-asserted-by":"crossref","unstructured":"L. Fang, G. Karakiulakis, M. Roth, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? vol. 8, The Lancet Respiratory Medicine. Lancet Publishing Group, 2020, p. e21.","DOI":"10.1016\/S2213-2600(20)30116-8"},{"key":"10.1016\/j.ijcha.2020.100660_b0060","article-title":"Antihypertensive drugs and risk of COVID-19? Vol. 8, The Lancet. Respiratory medicine","author":"Brown","year":"2020","journal-title":"NLM (Medline)"},{"key":"10.1016\/j.ijcha.2020.100660_b0065","unstructured":"Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers [Internet] (cited 2020 May 9). Available from: https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang."},{"key":"10.1016\/j.ijcha.2020.100660_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","author":"Kuster","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2020.100660_b0075","unstructured":"HFSA\/ACC\/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 - American College of Cardiology [Internet]. (cited 2020 May 9). Available from: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/03\/17\/08\/59\/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19."},{"issue":"6965","key":"10.1016\/j.ijcha.2020.100660_b0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ijcha.2020.100660_b0085","doi-asserted-by":"crossref","unstructured":"I.E. Sama, A. Ravera, B.T. Santema, H. Van Goor, J.M. Ter Maaten, J.G.F. Cleland et al., Circulating plasma concentrations of angiotensin-converting enzyme 2 inmen and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors, Eur. Heart J. [Internet], 2020 May 1 [cited 2020 Oct 2], 41(19), 1810\u20131817. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32388565\/.","DOI":"10.1093\/eurheartj\/ehaa373"},{"issue":"17","key":"10.1016\/j.ijcha.2020.100660_b0090","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.ijcha.2020.100660_b0095","doi-asserted-by":"crossref","unstructured":"K.E. Bernstein, Z. Khan, J.F. Giani, D.Y. Cao, E.A. Bernstein, X.Z. Shen, Angiotensin-converting enzyme in innate and adaptive immunity, vol. 14, Nature Reviews Nephrology. Nature Publishing Group, 2018, p. 325\u2013336.","DOI":"10.1038\/nrneph.2018.15"},{"key":"10.1016\/j.ijcha.2020.100660_b0100","doi-asserted-by":"crossref","unstructured":"G. Mancia, F. Rea, M. Ludergnani, G. Apolone, G. Corrao, Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of covid-19, N Engl. J. Med. [Internet], 2020 May 1 (cited 2020 May 9), NEJMoa2006923. Available from: http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2006923.","DOI":"10.1056\/NEJMoa2006923"},{"key":"10.1016\/j.ijcha.2020.100660_b0105","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcha.2020.100660_b0110","doi-asserted-by":"crossref","unstructured":"M.E. Flacco, C. Acuti Martellucci, F. Bravi, G. Parruti, R. Cappadona, A. Mascitelli et al., Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: a meta-analysis. Heart [Internet]. 2020 Jul 1 [cited 2020 Aug 11], pp. 1\u20136. Available from: http:\/\/dx.doi.org\/10.1136\/heartjnl-2020-317336.","DOI":"10.1136\/heartjnl-2020-317336"},{"key":"10.1016\/j.ijcha.2020.100660_b0115","doi-asserted-by":"crossref","unstructured":"A. Price, F. Barlow-Pay, S. Duffy, L. Pearce, A. Vilches-Moraga, S. Moug et al., Study protocol for the COPE study: COVID-19 in Older PEople: the influence of frailty and multimorbidity on survival. A multicentre, European observational study. BMJ Open [Internet]. 2020 Sep 29 [cited 2020 Oct 2], 10(9), e040569. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32994260.","DOI":"10.1136\/bmjopen-2020-040569"},{"key":"10.1016\/j.ijcha.2020.100660_b0120","unstructured":"B. Carter, J. Law, J. Hewitt, K.L. Parmar, J.M. Boyle, P. Casey et al., Association between preadmission frailty and care level at discharge in older adults undergoing emergency laparotomy, Br. J. Surg. [Internet]. 2020 Feb 1 [cited 2020 May 9], 107(3), 218\u2013226. Available from: http:\/\/doi.wiley.com\/10.1002\/bjs.11392."},{"key":"10.1016\/j.ijcha.2020.100660_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218534","article-title":"Lower-dose prescriptions in the post-marketing situation and the influencing factors thereon. Degtyar VE, editor","author":"Ogata","year":"2019","journal-title":"PLoS One [Internet]."},{"issue":"6","key":"10.1016\/j.ijcha.2020.100660_b0130","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinte.161.6.880","article-title":"Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians\u2019 Desk Reference","volume":"161","author":"Cohen","year":"2001","journal-title":"Arch Int. Med."},{"key":"10.1016\/j.ijcha.2020.100660_b0135","unstructured":"J. Hewitt, B. Carter, A. Vilches-Moraga, T.J. Quinn, P. Braude, A. Verduri et al., The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Heal [Internet] 2020 Aug 1 [cited 2020 Aug 11], 5(8), e444\u2013e451. Available from: www.thelancet.com\/."},{"key":"10.1016\/j.ijcha.2020.100660_b0140","doi-asserted-by":"crossref","unstructured":"D. Bean, Z. Kraljevic, T. Searle, R. Bendayan, A. Pickles, A. Folarin et al., Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust. medRxiv. 2020 Apr 11;2020.04.07.20056788.","DOI":"10.1101\/2020.04.07.20056788"},{"key":"10.1016\/j.ijcha.2020.100660_b0145","doi-asserted-by":"crossref","unstructured":"M. Baksh, V. Ravat, A. Zaidi, R.S. Patel, A systematic review of cases of acute respiratory distress syndrome in the coronavirus disease 2019 pandemic, Cureus [Internet], 2020 May 18 [cited 2020 Aug 11], 12(5). Available from: \/pmc\/articles\/PMC7301420\/?report=abstract.","DOI":"10.7759\/cureus.8188"},{"key":"10.1016\/j.ijcha.2020.100660_b0150","unstructured":"Randomised Evaluation of COVID-19 Therapy (RECOVERY) - Health Research Authority [Internet] [cited 2020 May 9]. Available from: https:\/\/www.hra.nhs.uk\/covid-19-research\/approved-covid-19-research\/281712\/."},{"key":"10.1016\/j.ijcha.2020.100660_b0155","doi-asserted-by":"crossref","unstructured":"C. Gao, C. Gao, Y. Cai, Y. Cai, K. Zhang, K. Zhang et al., Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study, Eur. Heart J. [Internet]. 2020 Jun 7 [cited 2020 Aug 11], 41(22), 2058\u20132066. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32498076\/.","DOI":"10.1093\/eurheartj\/ehaa433"},{"key":"10.1016\/j.ijcha.2020.100660_b0160","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906720303584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906720303584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:08:33Z","timestamp":1762492113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906720303584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"alternative-id":["S2352906720303584"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2020.100660","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2020.100660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100660"}}